Bruce Montgomery

CEO Avalyn Pharma

Dr. Montgomery has 30 years of pharmaceutical company experience in research, drug development, operations and financing. He has raised over 370 million dollars in venture or public financings. He has authored 26 US Patents and over 45 peer reviewed publications. Dr. Montgomery has been instrumental for three complete drug approvals, aerosolized pentamidine, tobramycin solution for inhalation, aztreonam lysine for inhalation (the only three FDA approved inhaled antimicrobials); from invention to advisory board presentations. From 1985 to 1989, Dr Montgomery was co-inventor, and then led the effort to obtain FDA approval of aerosolized pentamidine, the second AIDS drug approved by the FDA.

While at Genentech between 1989-1993, he started multiple other programs that have led to three other FDA approvals including Pulmozyme, Xolair and Raptiva. He has served as a board member for multiple companies and was a trustee of the Washington State Life Sciences Discovery Fund for a decade.

Dr. Montgomery received his Bachelor of Science in Chemistry in 1975 (Magna cum Laude, Outstanding Chemistry Major (Merck Award)), and Doctorate of Medicine in 1979 (Alpha Omega Alpha Honor Medical Society) from the University of Washington, Seattle. Dr. Montgomery is a board certified internist and pulmonologist.